How To Calculate Polydispersity Index Of Nanoparticles

Calculate the polydispersity index of your nanoparticle sample using dynamic light scattering (DLS) data

Comprehensive Guide: How to Calculate Polydispersity Index of Nanoparticles

The polydispersity index (PDI) is a dimensionless measure that indicates the degree of non-uniformity of a nanoparticle sample’s size distribution. A PDI value of 0 represents a perfectly uniform sample (monodisperse), while values greater than 0.7 typically indicate a very broad size distribution (highly polydisperse).

Understanding the Fundamentals of PDI

PDI is mathematically defined as the ratio of the weight-average molecular weight (M_w) to the number-average molecular weight (M_n), minus 1:

PDI = (M_w/M_n) – 1

For nanoparticle systems, this translates to the distribution of particle sizes rather than molecular weights. The most common techniques for measuring PDI include:

• Dynamic Light Scattering (DLS): Measures the time-dependent fluctuations in scattered light intensity caused by Brownian motion of particles in suspension
• Transmission Electron Microscopy (TEM): Provides direct visualization of nanoparticle sizes and shapes with nanometer resolution
• Scanning Electron Microscopy (SEM): Offers high-resolution surface imaging of nanoparticles
• Atomic Force Microscopy (AFM): Enables three-dimensional topography mapping of nanoparticles at atomic resolution

Step-by-Step Calculation Process

1. Sample Preparation:
   • Dilute nanoparticle suspension to appropriate concentration (typically 0.1-1 mg/mL)
   • Filter through 0.22 μm syringe filter to remove dust and aggregates
   • Equilibrate sample at measurement temperature (usually 25°C) for 10-15 minutes
2. Measurement:
   • For DLS: Perform at least 10 measurements with 10-30 second runs each
   • For TEM/SEM: Capture images of at least 200 particles from different regions
   • For AFM: Scan multiple 1×1 μm areas with sufficient resolution
3. Data Analysis:
   • For DLS: Use cumulants analysis to obtain intensity-weighted distribution
   • For microscopy: Use image analysis software to measure particle diameters
   • Calculate number-average (D_n) and intensity-average (D_z) diameters
4. PDI Calculation:

   Apply the formula:

   PDI = (σ/D_z)²

   where σ is the standard deviation of the particle size distribution and D_z is the z-average diameter

Interpreting PDI Values for Nanoparticles

PDI Range	Sample Quality	Typical Applications	Considerations
0.0 – 0.05	Excellent (monodisperse)	Quantum dots, viral vectors, lipid nanoparticles for mRNA delivery	Ideal for applications requiring precise size control
0.05 – 0.2	Good (narrow distribution)	Polymeric nanoparticles, solid lipid nanoparticles, some metallic nanoparticles	Acceptable for most biomedical applications
0.2 – 0.5	Moderate (broad distribution)	Iron oxide nanoparticles, some silica nanoparticles, emulsion systems	May require additional purification steps
0.5 – 0.7	Poor (very broad distribution)	Crude synthesis products, aggregated systems	Generally unsuitable for biomedical applications without further processing
> 0.7	Very poor (highly polydisperse)	Industrial catalysts, some environmental nanoparticles	Requires significant processing or alternative synthesis methods

Factors Affecting PDI Measurements

Instrument-Related Factors

• Laser wavelength (typically 633 nm for DLS)
• Scattering angle (90° most common, 173° for better resolution)
• Detector sensitivity and noise levels
• Temperature control accuracy (±0.1°C ideal)

Sample-Related Factors

• Particle concentration (too high causes multiple scattering)
• Solvent viscosity and refractive index
• Particle shape (non-spherical particles affect hydrodynamic diameter)
• Surface charge and stabilization (affects aggregation state)

Data Processing Factors

• Analysis algorithm (cumulants vs. CONTIN vs. NNLS)
• Baseline correction methods
• Outlier rejection criteria
• Number of measurements averaged

Comparison of PDI Measurement Techniques

Technique	Size Range (nm)	PDI Resolution	Sample Requirements	Advantages	Limitations
Dynamic Light Scattering	0.3 – 10,000	Moderate	10-100 μL, 0.1-1 mg/mL	Fast, non-destructive, widely available	Sensitive to dust, assumes spherical particles
Transmission Electron Microscopy	1 – 1000+	High	Dry sample, ultra-thin sections	Direct visualization, high resolution	Time-consuming, potential artifacts from drying
Scanning Electron Microscopy	5 – 100,000	High	Dry sample, conductive coating	Surface topography, large size range	Vacuum required, potential charging artifacts
Atomic Force Microscopy	0.1 – 10,000	Very High	Dry or liquid sample	3D topography, works in liquid	Slow scanning, limited sample area
Field-Flow Fractionation	1 – 1000	High	100 μL – 1 mL, 0.01-1 mg/mL	Separates by size, can couple with other detectors	Complex instrumentation, longer analysis time

Advanced Considerations for Nanoparticle PDI

For specialized applications, several advanced factors must be considered when interpreting PDI values:

1. Core-Shell Structures:

   Nanoparticles with core-shell architectures (e.g., gold core with silica shell) present unique challenges. The PDI may reflect either:

   • Size distribution of complete core-shell particles
   • Separate distributions of cores and shells if not uniformly coated
   • Artifacts from differential scattering intensities of core vs. shell materials

   Solution: Combine DLS with TEM for comprehensive characterization

2. Anisotropic Particles:

   Non-spherical nanoparticles (rods, plates, stars) require specialized analysis:

   • DLS reports hydrodynamic diameter of equivalent sphere
   • TEM/SEM can provide aspect ratio distributions
   • Small-angle X-ray scattering (SAXS) offers shape information

   Solution: Report both equivalent spherical diameter PDI and aspect ratio distribution

3. Biological Nanoparticles:

   Viral vectors, exosomes, and protein nanoparticles have unique considerations:

   • Soft corona formation affects hydrodynamic size
   • Biological activity may correlate with PDI
   • Storage conditions dramatically impact stability

   Solution: Measure PDI in relevant biological media at physiological temperature

Practical Applications of PDI in Nanotechnology

Drug Delivery Systems

PDI directly impacts:

• Pharmacokinetics and biodistribution
• Cellular uptake efficiency
• Drug loading capacity and release profiles
• Immune system recognition and clearance

Optimal PDI for most drug delivery applications: 0.05-0.2

Diagnostic Nanoparticles

PDI affects:

• Optical properties (for plasmonic nanoparticles)
• Magnetic resonance signal (for iron oxide nanoparticles)
• Targeting efficiency and specificity
• Clearance rates from circulation

Optimal PDI for diagnostic applications: 0.0-0.15

Industrial Catalysts

PDI influences:

• Active surface area
• Catalytic efficiency and selectivity
• Long-term stability and fouling resistance
• Mass transfer properties

Acceptable PDI for catalytic applications: 0.1-0.5

Troubleshooting Common PDI Measurement Issues

1. High PDI Values (>0.7) When Expected to Be Low:
   • Cause: Dust contamination or aggregates
   • Solution: Filter through 0.1 μm syringe filter, centrifuge at 10,000×g for 10 min
2. Inconsistent PDI Between Measurements:
   • Cause: Temperature fluctuations or sample evaporation
   • Solution: Use sealed cuvettes, equilibrate for 15+ minutes, verify temperature control
3. PDI Values Below Expected Range:
   • Cause: Multiple scattering at high concentrations
   • Solution: Dilute sample, verify appropriate concentration range for instrument
4. Discrepancies Between DLS and Microscopy PDI:
   • Cause: Different weighting (intensity vs. number distribution)
   • Solution: Report both intensity-average and number-average PDI values

Emerging Techniques for PDI Measurement

Several advanced techniques are gaining traction for more accurate PDI characterization:

• Nanoparticle Tracking Analysis (NTA):

  Tracks individual particles via light scattering and Brownian motion, providing number-based size distributions. Particularly useful for samples with PDI 0.1-0.5 where DLS may be less accurate.

• Resistive Pulse Sensing:

  Measures particle-by-particle as they pass through a nanopore, offering absolute size distributions. Excellent for PDI 0.05-0.3 range with high resolution.

• Single Particle ICP-MS:

  Detects individual nanoparticles by their metal content, enabling size distribution analysis of metallic nanoparticles with PDI as low as 0.01.

• Machine Learning-Enhanced DLS:

  New algorithms can deconvolute complex distributions and improve PDI accuracy for multimodal samples.

Regulatory Considerations for PDI in Nanomedicine

The polydispersity index has become a critical quality attribute for nanoparticle-based medicinal products. Regulatory agencies provide specific guidance:

• FDA Guidance (2022):

  For lipid nanoparticles in drug products, PDI should be ≤0.2 with justification provided for values up to 0.3. Batch-to-batch variability should not exceed ±0.05.

• EMA Reflection Paper (2021):

  Recommends reporting both intensity-weighted and number-weighted PDI for nanoparticle medicines. Values >0.3 require additional characterization and risk assessment.

• ISO/TS 19430 (2020):

  Standardizes DLS measurement protocols for nanoparticles in biological media, including PDI calculation methods and reporting requirements.

For comprehensive regulatory guidelines, refer to:

• FDA’s Liposome Drug Products Guidance
• EMA’s Nanomedicine Quality Guidelines

Future Directions in PDI Characterization

The field of nanoparticle characterization is rapidly evolving with several exciting developments:

1. In Situ PDI Monitoring:

   Real-time PDI measurement during nanoparticle synthesis using flow-through DLS or SAXS cells, enabling precise control over reaction conditions to achieve target PDI values.

2. Correlative Microscopy Approaches:

   Combining liquid-cell TEM with DLS to provide simultaneous visual and statistical characterization of nanoparticles in their native environment.

3. AI-Powered Data Analysis:

   Machine learning algorithms that can predict PDI from synthesis parameters or automatically classify nanoparticle batches based on PDI and other quality attributes.

4. Standard Reference Materials:

   Development of nanoparticle reference materials with certified PDI values for instrument calibration and method validation across different techniques.

For researchers seeking to deepen their understanding of nanoparticle characterization, the following resources from authoritative institutions are invaluable:

• NIST Nanomaterial Reference Materials – Comprehensive standards for nanoparticle characterization
• NCI Alliance for Nanotechnology in Cancer Characterization Resources – Protocols and best practices for nanoparticle characterization in biomedical applications
• ISO/TC 229 Nanotechnologies Standards – International standards for nanoparticle measurement and characterization